Manufacturing Process Of Tetra-N-Butylammonium Chloride Hydrate At Scale

• Industrial synthesis of Tetra-n-Butylammonium Chloride Hydrate relies on a quaternization reaction between tributylamine and n-butyl chloride under controlled thermal conditions.
• NINGBO INNO PHARMCHEM CO.,LTD. implements closed-loop solvent recovery and rigorous in-process analytics to ensure >99% industrial purity and batch consistency.
• Bulk procurement is optimized through ISO 9001-certified continuous production, with full COA documentation available for pharmaceutical and phase-transfer catalyst applications.

The large-scale manufacturing process of Tetrabutylammonium Chloride Hydrate (CAS: 37451-68-6) is a cornerstone of modern phase-transfer catalysis and cold energy storage material synthesis. As a globally traded quaternary ammonium salt, its industrial relevance spans organic synthesis, electrochemistry, and semiclathrate hydrate research. When sourcing high-purity Tetrabutylammonium Chloride Hydrate, buyers must prioritize suppliers with validated scale-up capabilities and stringent quality controls—criteria met by premier global manufacturer NINGBO INNO PHARMCHEM CO.,LTD.

Step-by-Step Large-Scale Production Process Under GMP or ISO Standards

The core synthesis route for Tetra-n-Butylammonium Chloride Hydrate involves the nucleophilic substitution (quaternization) of tributylamine with n-butyl chloride:

(C₄H₉)₃N + C₄H₉Cl → (C₄H₉)₄N⁺Cl⁻

This exothermic reaction is conducted in a polar aprotic solvent (e.g., acetonitrile or toluene) at 60–80°C for 12–24 hours under nitrogen atmosphere to prevent oxidation. At NINGBO INNO PHARMCHEM CO.,LTD., the process is executed in jacketed glass-lined or Hastelloy reactors equipped with precise temperature control and reflux condensers to manage volatile organics.

Post-reaction, the crude product is concentrated under reduced pressure. The resulting solid is then recrystallized from ethanol/water mixtures to yield the hydrate form. Final drying occurs under vacuum at 40–50°C to achieve a stable water content (typically 5–8% H₂O), consistent with the hydrate stoichiometry. Throughout production, in-process testing—including pH, conductivity, and Karl Fischer titration—ensures compliance with pharmacopeial standards for intermediates.

Quality Assurance and Industrial Purity

NINGBO INNO PHARMCHEM CO.,LTD. maintains an industrial purity of ≥99.0% (by HPLC and titration), with strict limits on residual solvents (<500 ppm), heavy metals (<10 ppm), and chloride ion balance. Each batch is accompanied by a comprehensive Certificate of Analysis (COA), detailing assay, appearance, melting range (75–80°C), and water content—critical for reproducible performance in catalytic or hydrate-forming applications.

Solvent Recovery and Waste Management in Continuous Synthesis

To align with green chemistry principles and reduce operational costs, NINGBO INNO PHARMCHEM CO.,LTD. employs integrated solvent recovery systems. Distillation units reclaim >95% of acetonitrile or toluene for reuse, minimizing raw material consumption and hazardous waste generation. Aqueous wash streams undergo pH neutralization and filtration before discharge, adhering to ISO 14001 environmental management protocols.

This closed-loop approach not only enhances sustainability but also stabilizes the bulk price structure by mitigating volatility in solvent markets—a key advantage for long-term B2B contracts.

Ensuring Batch-to-Batch Consistency for Pharmaceutical Intermediates

For clients in fine chemicals and API synthesis, consistency is non-negotiable. NINGBO INNO PHARMCHEM CO.,LTD. utilizes statistical process control (SPC) across all production runs, monitoring critical parameters such as reaction conversion (>98%), crystallization yield (85–90%), and particle size distribution (D50: 150–300 µm). This ensures uniform dissolution kinetics and catalytic activity—essential for scalable organic transformations like Williamson ether synthesis or nucleophilic substitutions.

Furthermore, the company’s R&D team continuously optimizes the synthesis route to improve atom economy and reduce impurity profiles, directly supporting customers’ regulatory filings under ICH Q11 guidelines.

Technical Comparison: Key Process Metrics

Parameter	Standard Specification	NINGBO INNO PHARMCHEM CO.,LTD. Control Range
Purity (HPLC)	≥98.0%	99.0–99.5%
Water Content (KF)	5.0–9.0%	6.0–7.5%
Residual Solvents	<1000 ppm	<300 ppm
Batch Size Capacity	10–100 kg	50–500 kg per campaign
Lead Time (Bulk)	4–6 weeks	2–3 weeks (with inventory buffer)

In summary, the industrial-scale production of tetrabutyl ammonium chloride hydrate demands precision in reaction engineering, crystallization control, and analytical validation. NINGBO INNO PHARMCHEM CO.,LTD. stands as a trusted global manufacturer offering not only high-purity material but also technical partnership—from kilo lab to multi-ton supply—for applications demanding reliability and performance.